{"disease":{"id":"severe-acute-respiratory-infection","name":"severe acute respiratory infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05620953","title":"Severe Acute Respiratory Infections (SARI) in Belgium (2011-2020)","phase":"","overall_status":"COMPLETED","enrollment_count":12145,"lead_sponsor_name":"Sciensano","has_results":false},{"nct_id":"NCT04542915","title":"COVID-19-Related Health and Practices Among Dental Hygienists","phase":"","overall_status":"COMPLETED","enrollment_count":6976,"lead_sponsor_name":"American Dental Association","has_results":false},{"nct_id":"NCT04367740","title":"ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":6313,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT04627623","title":"Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration","phase":"","overall_status":"UNKNOWN","enrollment_count":6000,"lead_sponsor_name":"Medical University of Silesia","has_results":false},{"nct_id":"NCT05458557","title":"Antigen Rapid Diagnostic Tests for Community Identification of Severe Acute Respiratory Syndrome Coronavirus 2","phase":"","overall_status":"COMPLETED","enrollment_count":5000,"lead_sponsor_name":"Elizabeth Glaser Pediatric AIDS Foundation","has_results":false},{"nct_id":"NCT04540185","title":"A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":3600,"lead_sponsor_name":"Biomed Industries, Inc.","has_results":false},{"nct_id":"NCT04490850","title":"COVID-19 Seroprevalence Study in French Guiana","phase":"NA","overall_status":"COMPLETED","enrollment_count":3541,"lead_sponsor_name":"Institut Pasteur","has_results":false},{"nct_id":"NCT04354779","title":"Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.","phase":"","overall_status":"COMPLETED","enrollment_count":3301,"lead_sponsor_name":"AUVA","has_results":false},{"nct_id":"NCT05582239","title":"Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in Adults","phase":"","overall_status":"UNKNOWN","enrollment_count":2400,"lead_sponsor_name":"ANRS, Emerging Infectious Diseases","has_results":false},{"nct_id":"NCT05629962","title":"SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2285,"lead_sponsor_name":"Atea Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT07279298","title":"Effectiveness of Immunization in Preventing Severe Acute Respiratory Infection RSV","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1097,"lead_sponsor_name":"Bogotá District Health Secretariat","has_results":false},{"nct_id":"NCT04452565","title":"NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":525,"lead_sponsor_name":"Biomed Industries, Inc.","has_results":false},{"nct_id":"NCT04847141","title":"A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":465,"lead_sponsor_name":"Grifols Therapeutics LLC","has_results":true},{"nct_id":"NCT04476979","title":"Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":453,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04711863","title":"Fluvoxamine for Adults With Mild to Moderate COVID-19","phase":"PHASE2","overall_status":"SUSPENDED","enrollment_count":400,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT05290454","title":"mNGS -Guided Antimicrobial Treatment in Early Severe Community-Acquired Pneumonia Among Immunocompromised Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":342,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false},{"nct_id":"NCT04328129","title":"Household Transmission Investigation Study for COVID-19 in Tropical Regions","phase":"NA","overall_status":"COMPLETED","enrollment_count":245,"lead_sponsor_name":"Institut Pasteur","has_results":false},{"nct_id":"NCT04322188","title":"An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications","phase":"","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"A.O. Ospedale Papa Giovanni XXIII","has_results":false},{"nct_id":"NCT04323592","title":"Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":173,"lead_sponsor_name":"University of Trieste","has_results":true},{"nct_id":"NCT04720794","title":"A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion","phase":"NA","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"Lucira Health Inc","has_results":false},{"nct_id":"NCT04659486","title":"Adolescents With COVID-19/MIS-C at HCFMUSP","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"University of Sao Paulo","has_results":false},{"nct_id":"NCT04822818","title":"EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04365101","title":"Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":86,"lead_sponsor_name":"Celularity Incorporated","has_results":false},{"nct_id":"NCT04432272","title":"ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":71,"lead_sponsor_name":"Corewell Health East","has_results":true},{"nct_id":"NCT04365985","title":"Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":70,"lead_sponsor_name":"Corewell Health East","has_results":true},{"nct_id":"NCT06409663","title":"A Strain Change Study for SARS-CoV-2 rS Vaccines","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Novavax","has_results":false},{"nct_id":"NCT04409873","title":"Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":54,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT04615052","title":"Home-based Exercise in COVID-19 Survivors","phase":"NA","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"University of Sao Paulo","has_results":false},{"nct_id":"NCT04584658","title":"Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study)","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Cambridge University Hospitals NHS Foundation Trust","has_results":false},{"nct_id":"NCT05693272","title":"A Clinical Trial to Study the COVAC-1 Booster Dose in Generally Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"University of Saskatchewan","has_results":false},{"nct_id":"NCT04839146","title":"Safety and Tolerability of COVID-19 Vaccine (ABNCoV2)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Radboud University Medical Center","has_results":true},{"nct_id":"NCT04480333","title":"Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":45,"lead_sponsor_name":"Biomed Industries, Inc.","has_results":false},{"nct_id":"NCT03168282","title":"Evaluation of Culture Negative Severe Acute Respiratory Infection in Mexico","phase":"","overall_status":"TERMINATED","enrollment_count":32,"lead_sponsor_name":"Mexican Emerging Infectious Diseases Clinical Research Network","has_results":false},{"nct_id":"NCT06291883","title":"Evaluation of KGR Prescriptions in Suppressing COVID-19 Infection.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Sheng-Teng Huang","has_results":false},{"nct_id":"NCT04433949","title":"Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":14,"lead_sponsor_name":"Emory University","has_results":false},{"nct_id":"NCT06627166","title":"Viral Etiology of Severe Acute Respiratory InFection in CriticallY Ill Patients Registry","phase":"","overall_status":"TERMINATED","enrollment_count":13,"lead_sponsor_name":"King Abdullah International Medical Research Center","has_results":false},{"nct_id":"NCT04664075","title":"Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)","phase":"","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Imperial College London","has_results":true},{"nct_id":"NCT04708457","title":"The REDEEM Pilot Study: A Feasibility RCT of Early ECMO in Severe Acute Respiratory Infection, Including COVID-19, WHO","phase":"NA","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Australian and New Zealand Intensive Care Research Centre","has_results":false},{"nct_id":"NCT05711810","title":"Medicine-induced Cardiac Hemodialysis on COVID-19","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1,"lead_sponsor_name":"Yang I. Pachankis","has_results":false},{"nct_id":"NCT04370834","title":"Tocilizumab for Patients With Cancer and COVID-19 Disease","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true}],"total":40},"guidelines":[],"source":"Drug Landscape verified database"}